Breakthroughs from clinical trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Gastric Acid Heart Conduction System Pericardium Pulmonary Veins Heart Atria Endometrium Brain

Organisms9

Hepatitis B virus Babesia bovis Clostridium tertium Candida Trichosporon Herpesvirus 3, Human HIV-1 Fungi Hepacivirus

Diseases37

Breakthrough Pain Neoplasms Chickenpox Metrorrhagia Fungemia Hepatitis B, Chronic Recurrence Pain Labor Pain Mycoses Zygomycosis Uterine Hemorrhage Candidiasis Disease Progression Trichosporonosis HIV Infections Vesico-Ureteral Reflux Neutropenia Chronic Disease Gastroesophageal Reflux Disease Models, Animal Febrile Neutropenia Nausea Breast Neoplasms Atrial Fibrillation Hematologic Neoplasms Stroke Pain, Intractable Aspergillosis Fever Lung Neoplasms Hepatitis B Bacteremia Acute Disease Nervous System Diseases Drug-Related Side Effects and Adverse Reactions Opportunistic Infections

Chemicals and Drugs51

Lamivudine Antiviral Agents Fentanyl Levonorgestrel Placebos Antineoplastic Agents Analgesics, Opioid Antifungal Agents Organophosphonates Hepatitis B e Antigens Charcoal Contraceptive Agents, Female 2-Pyridinylmethylsulfinylbenzimidazoles Echinocandins Adenine Omeprazole Triazoles Anti-Ulcer Agents Reverse Transcriptase Inhibitors Vaginal Creams, Foams, and Jellies Iridium Carboxin Anti-HIV Agents Lansoprazole Fluconazole Drugs, Investigational Alanine Transaminase Antibodies, Monoclonal Guanine Rabeprazole Anti-Bacterial Agents Amphotericin B Pyrimidines Ribavirin Radioisotopes Benzimidazoles DNA, Viral Lipopeptides Proton Pump Inhibitors Interferon-alpha Piperazines Polyethylene Glycols Drug Combinations Anticonvulsants Antibodies, Monoclonal, Humanized Biological Markers Progestins Recombinant Proteins Peptides, Cyclic Protozoan Vaccines Silicon Dioxide

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Clinical Trials as Topic Radionuclide Generators Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Administration, Buccal Drug Therapy, Combination Randomized Controlled Trials as Topic Respiratory Protective Devices Patient Selection Prospective Studies Follow-Up Studies Drug Administration Schedule Epicardial Mapping Multicenter Studies as Topic Placebos Clinical Trials, Phase IV as Topic Body Surface Potential Mapping Gastric Acidity Determination Clinical Protocols Treatment Failure Therapeutics Chemoprevention Administration, Oral Single-Blind Method Early Termination of Clinical Trials Retrospective Studies Intrauterine Devices, Medicated Cross-Over Studies Risk Factors Pain Measurement Severity of Illness Index Sample Size Gloves, Protective Pilot Projects Drug Substitution Vaginal Creams, Foams, and Jellies Reproducibility of Results Questionnaires Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Endpoint Determination Drug Discovery Vaccination Prognosis Molecular Targeted Therapy Survival Analysis Disease Models, Animal Viral Load Models, Biological Drug Delivery Systems Drug Evaluation, Preclinical Predictive Value of Tests Reverse Genetics Data Interpretation, Statistical Genetic Therapy Drug Evaluation Feasibility Studies Drug Design Disease-Free Survival Incidence Survival Rate Risk Assessment Exercise Therapy Cardiac Pacing, Artificial Therapeutic Human Experimentation Electrophysiologic Techniques, Cardiac Drug Approval Random Allocation Stem Cell Transplantation Meta-Analysis as Topic Genetic Engineering Infusions, Intravenous Equipment Design Antibiotic Prophylaxis Analgesia, Epidural Phytotherapy Magnetic Resonance Imaging Analysis of Variance Chemotherapy, Adjuvant Kaplan-Meier Estimate Catheter Ablation Immunotherapy Electrocardiography Neoplasm Staging

Psychiatry and Psychology5

Breakthrough Pain Pain Patient Compliance Cooperative Behavior Cognitive Therapy

Phenomena and Processes17

Breakthrough Pain Time Factors Pain Drug Resistance, Viral Dose-Response Relationship, Drug Mutation Viral Load Pregnancy Algorithms Drug Resistance, Fungal Adsorption Circadian Rhythm Signal Transduction Genotype Genetic Vectors Immunocompromised Host Hydrogen-Ion Concentration

Disciplines and Occupations11

Research Design Biomedical Research Outcome Assessment (Health Care)Drug Discovery Evidence-Based Medicine Biotechnology Medical Oncology Drug Design Therapeutic Human Experimentation Regenerative Medicine Research

Anthropology, Education, Sociology and Social Phenomena8

United States Food and Drug Administration Quality of Life Informed Consent Forecasting Drug Approval Patient Education as Topic National Cancer Institute (U.S.)National Institutes of Health (U.S.)

Technology, Industry, Agriculture6

Respiratory Protective Devices Gloves, Protective Drug Industry Biotechnology Dietary Supplements Polyethylene Glycols

Humanities9

History, 20th Century History, 21st Century History, 19th Century Quality of Life History, 17th Century History, 16th Century Nobel Prize History, 18th Century Ethics Committees, Research

Information Science7

Questionnaires Algorithms Data Interpretation, Statistical Incidence Survival Rate Molecular Sequence Data Publishing

Named Groups3

Research Subjects Infant, Newborn Patient Dropouts

Health Care59

Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Randomized Controlled Trials as Topic Patient Selection Prospective Studies Follow-Up Studies Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Clinical Protocols Treatment Failure Precipitating Factors Single-Blind Method Early Termination of Clinical Trials Retrospective Studies Cross-Over Studies Risk Factors United States Food and Drug Administration Severity of Illness Index Sample Size Pilot Projects Drug Substitution Reproducibility of Results Questionnaires Outcome Assessment (Health Care)Cost-Benefit Analysis Vaccination Survival Analysis Patient Compliance Informed Consent Placebo Effect Predictive Value of Tests Practice Guidelines as Topic Data Interpretation, Statistical Patient Participation Feasibility Studies Disease-Free Survival Age Factors Incidence Survival Rate Risk Assessment Intention to Treat Analysis Random Allocation Meta-Analysis as Topic Patient Education as Topic Patient Satisfaction Research Support as Topic Bias (Epidemiology)Analysis of Variance National Cancer Institute (U.S.)Guidelines as Topic Kaplan-Meier Estimate National Institutes of Health (U.S.)Ethics Committees, Research

Geographicals3

United States Slovakia Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Breakthrough Pain Radionuclide Generators Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Lamivudine Administration, Buccal Neoplasms Time Factors Chickenpox Drug Therapy, Combination Antiviral Agents Randomized Controlled Trials as Topic Respiratory Protective Devices Fentanyl Patient Selection Metrorrhagia Fungemia Hepatitis B, Chronic Prospective Studies Follow-Up Studies Drug Administration Schedule Epicardial Mapping Multicenter Studies as Topic Levonorgestrel Placebos Clinical Trials Data Monitoring Committees Antineoplastic Agents Analgesics, Opioid History, 20th Century Antifungal Agents Clinical Trials, Phase IV as Topic Body Surface Potential Mapping Gastric Acidity Determination Clinical Protocols Recurrence Organophosphonates Pain United States Treatment Failure History, 21st Century Drug Resistance, Viral Hepatitis B e Antigens Therapeutics Precipitating Factors Chemoprevention Administration, Oral Single-Blind Method Charcoal Biomedical Research Contraceptive Agents, Female Labor Pain Early Termination of Clinical Trials Retrospective Studies 2-Pyridinylmethylsulfinylbenzimidazoles Intrauterine Devices, Medicated Cross-Over Studies Gastric Acid Risk Factors United States Food and Drug Administration Echinocandins Dose-Response Relationship, Drug Adenine Pain Measurement Mycoses Zygomycosis Omeprazole History, 19th Century Slovakia Severity of Illness Index Triazoles Hepatitis B virus Heart Conduction System Sample Size Gloves, Protective Anti-Ulcer Agents Uterine Hemorrhage Drug Industry Quality of Life Pilot Projects History, 17th Century Babesia bovis Candidiasis Research Subjects Reverse Transcriptase Inhibitors Disease Progression Trichosporonosis Drug Substitution HIV Infections Vaginal Creams, Foams, and Jellies Reproducibility of Results Questionnaires Iridium Vesico-Ureteral Reflux Neutropenia

No FAQ available that match "breakthroughs from clinical trials"